Functional and clinical implications of cardiac resynchronization therapy on outcomes of diabetic patients with heart failure

Journal of Cardiovascular Medicine

Volumn 12, Issue 6, 2011, Pages 396-400

  Santangelo, Gloria ^a   Dugo, Daniela ^a   Mulè, Massimiliano ^a   Puzzangara, Euglena ^a   Schillaci, Vincenzo ^a   Timineri, Salvatore ^a   Capranzano, Piera ^a   Di Grazia, Angelo ^a   Liotta, Claudio ^a   Scandura, Salvatore ^a   Ragusa, Antonio ^a   Tamburino, Corrado ^a   Calvi, Valeria ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

cardiac resynchronization therapy; clinical outcomes; diabetes mellitus; echocardiographic outcomes; heart failure

Indexed keywords

INSULIN;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CAUSE OF DEATH; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE CONDUCTION; HEART VENTRICLE WALL MOTION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; TREATMENT INDICATION; TREATMENT OUTCOME;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; DIABETES COMPLICATIONS; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 79955871931     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e328341da34     Document Type: Article

References (35)

1. American Diabetes Association. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20:1183-1197.
2. Suskin N, McKelvie RS, Burns RJ, Latini R, Pericak D, Probstfield J, et al. Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. Eur Heart J 2000; 21:1368-1375. (Pubitemid 30599132)
3. Schindler DM, Kostis JB, Yusuf S, Quinones MA, Pitt B, Stewart D, et al. Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLD) trials and registry. Am J Cardiol 1996; 77:1017-1020. (Pubitemid 26158096)
4. De Groote P, Lamblin N, Mouquet F, Plichon D, McFadden E, Van Belle E, Bauters C. Impact of diabetes mellitus on long-term survival in patients with congestive heart failure. Eur Heart J 2004; 25:656-662. (Pubitemid 38579494)
5. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, et al., The Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001; 344:873-880. (Pubitemid 32224395)
6. Bristow MR, Fedmann AM, Saxon LA, for the COMPANION steering committee and COMPANION clinical investigators. Heart failure management using implantable devices for ventricular resynchronization: Comparison of Medical Therapy, pacing, and Defibrillation in Chronic Heart failure (COMPANION) trial. J Card Fail 2000; 6:276-285.
7. Asbun J, Villareal FJ. The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. J Am Coll Cardiol 2006; 47:693-700. (Pubitemid 43243087)
8. Chatterjee K. Refractory heart failure: drugs and devices. Eur Heart J 2001; 22:2227-2230. (Pubitemid 34000976)
9. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al., ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. The task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008; 29:2388-2442.
10. Pitzalis MV, Iacovello M, Romito R, Guida P, De Tommasi E, Luzzi G, et al. Ventricular asynchrony predicts a better outcome in patients with chronic heart failure receiving cardiac resynchronization therapy. J Am Coll Cardiol 2005; 45:65-69. (Pubitemid 40052027)
11. Rouleau F, Merhen M, Geffroy S, Berthelot J, Chaleil D, Dupuis JM, et al. Echocardiographic assessment of the interventricular delay of activation and correlation to the QRS width in dilated cardiomyopathy. Pacing Clin Electrophysiol 2001; 24:1500-1506. (Pubitemid 32977308)
12. Cazeau S, Jauvert G, Alonso C, Bordachar P, Lazarus A, Ritter P. Echocardiographic modelling of cardiac asynchronism: prospective evaluation before and after multisite stimulation - a prospective study. Pacing Clin Electrophysiol 2003; 26:137-143. (Pubitemid 36399126)
13. Porciani MC, Dondina C, Macioce R, Demarchi G, Pieragnoli P, Musilli N, et al. Echocardiographic examination of atrioventricular and interventricular delay optimization in cardiac resynchronization therapy. Am J Cardiol 2005; 95:1108-1110. (Pubitemid 40544322)
14. Bax JJ, Marwick TH, Molhoek SG, Bleeker GB, van Erven L, Boersma E, et al. Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantation. Am J Cardiol 2003; 92:1238-1240. (Pubitemid 37377846)
15. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005) - The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26:1115-1140.
16. Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur Heart J 2007; 28:2256-2295. (Pubitemid 47428944)
17. Sheadedh A, Regan TJ. Cardiac consequences of diabetes mellitus. Clin Cardiol 1994; 18:301-305.
18. Bell DS. The frequent, forgotten, and often fatal complication of diabetes. Diabetes Care 2003; 26:2433-2441. (Pubitemid 36993339)
19. Bristow M. Etomoxir. A new approach to treatment of chronic heart failure. Lancet 2000; 356:1621-1622.
20. Cosentino F, Tishikawa K, Katuzuc ZS, Luscher TF. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 1997; 96:25-28. (Pubitemid 27298398)
21. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352:1539-1549. (Pubitemid 40517094)
22. Kiè s P, Bax JJ, Molhoek SG, Bleeker GB, Boersma E, Steendijk P, et al. Comparison of effectiveness of cardiac resynchronization therapy in patients with versus without diabetes mellitus. Am J Cardiol 2005; 96:108-111. (Pubitemid 40853952)
23. Hoppe UC, Freemantle N, Cleland JG, Marijianowski M, Erdmann E. Effect of cardiac resynchronization on morbidity and mortality of diabetic patients with severe heart failure. Diabetes Care 2007; 30:722-724. (Pubitemid 46354361)
24. Fantoni C, Regoli F, Ghanem A, Raffa S, Klersy C, Sorgente A, et al. Longterm outcome in diabetic heart failure patients treated with cardiac resynchronization therapy. Eur Heart J 2008; 10:298-307.
25. Mangiavacchi M, Gasparini M, Genovese S, Pini D, Klersy C, Bragato R, et al. Insulin-treated type 2 diabetes is associated with a decreased survival in heart failure patients after cardiac resynchronization therapy.. Pacing Clin Electrophysiol 2008; 31:1425-1432.
26. Yu CM, Fung JWH, Zhang Q, Sanderson JE. Understanding nonresponders of cardiac resynchronization therapy: current and future perspectives. J Cardiovasc Electrophysiol 2005; 16:1117-1124.
27. Abraham WT, Hayes DL. Cardiac resynchronization therapy for heart failure. Circulation 2003; 108:2596-2603. (Pubitemid 37466796)
28. Reuter S, Garrigue S, Barod S, Jais P, Hocini M, Haissaguerre M, Clementy J. Comparison of characteristics in responders versus nonresponders with biventricular pacing for drug-resistant congestive heart failure. Am J Cardiol 2002; 89:346-350. (Pubitemid 34113801)
29. Saxon LA, De Marco T, Schafer J, Chatterjee K, Kumar UN, Foster E. Effects of long-term biventricular stimulation for resynchronization on echocardiographic measures of remodeling. Circulation 2002; 105:1304-1310. (Pubitemid 34260420)
30. LecoqG, Leclercq C, Leray E, Crocq C, Alonso C, de Place C, et al. Clinical and electrocardiographic predictors of a positive response to cardiac resynchronization therapy in advanced heart failure. Eur Heart J 2005; 26:1094-1100. (Pubitemid 40839910)
31. Ghio S, Constantin C, Klersy C, Serio A, Fontana A, Campana C, Tavazzi L. Interventricular and intraventricular dyssynchrony are common in heart failure patients, regardless of QRS duration. Eur Heart J 2004; 25:571-578. (Pubitemid 38478550)
32. Bleeker GB, Schalij MJ, Molhoek S, Verwey HF, Holman ER, Boersma E, et al. Relationship between QRS duration and left ventricular dyssynchrony in patients with end-stage heart failure. J Cardiovasc Electrophysiol 2004; 15:544-549. (Pubitemid 38621905)
33. Bader H, Garrigue S, Lafitte S, Reuter S, Jaïs P, Haïssaguerre M, et al. Intraleft ventricular electromechanical asynchrony. A new independent predictor of severe cardiac events in heart failure patients. J Am Coll Cardiol 2004; 43:248-256. (Pubitemid 38201152)
34. Cho GY, Song JK, Park WJ, Han SW, Choi SH, Doo YC, et al. Mechanical dyssynchrony assessed by tissue Doppler imaging is a powerful predictor of mortality in congestive heart failure with normal QRS duration. J Am Coll Cardiol 2005; 46:2237-2243.
35. Bax JJ, Ansalone G, Breithardt OA, Derumeaux G, Leclercq C, Schalij MJ, et al. Echocardiographic evaluation of cardiac resynchronization therapy: ready for routine clinical use? A critical appraisal. J Am Coll Cardiol 2004; 44:1-9.-pii 012446652011060000 (Pubitemid 38968446)